You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study
|
---|---|
Published in |
BMC Cancer, December 2013
|
DOI | 10.1186/1471-2407-13-615 |
Pubmed ID | |
Authors |
Zsuzsanna Varga, Aurelia Noske, Constanze Ramach, Barbara Padberg, Holger Moch |
Abstract |
The gold standard of HER2 status assessment in breast cancer is still debated. Immunohistochemistry (IHC) and in-situ technology as fluorescent-labeled methodology (FISH) can be influenced by pre-analytical factors, assay-conditions and interpretation of test results. We retrospectively conducted this quality control study and analyzed HER2 test results in breast cancer within the routine diagnostic service in a single institution over a period of 12 years. We addressed the question how stable and concordant IHC and FISH methods are and whether HER2 positivity rate has changed over this period. |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 58 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 11 | 19% |
Student > Bachelor | 8 | 14% |
Other | 5 | 8% |
Researcher | 4 | 7% |
Lecturer | 3 | 5% |
Other | 10 | 17% |
Unknown | 18 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 24% |
Agricultural and Biological Sciences | 8 | 14% |
Biochemistry, Genetics and Molecular Biology | 6 | 10% |
Unspecified | 2 | 3% |
Nursing and Health Professions | 2 | 3% |
Other | 4 | 7% |
Unknown | 23 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2023.
All research outputs
#4,516,071
of 24,404,997 outputs
Outputs from BMC Cancer
#1,091
of 8,665 outputs
Outputs of similar age
#51,228
of 315,418 outputs
Outputs of similar age from BMC Cancer
#12
of 99 outputs
Altmetric has tracked 24,404,997 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,665 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,418 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.